Autonomix Medical Inc. Common Stock (AMIX)
Stock · NASDAQ · Health Care
$2.85as of 10/16/2026
Price chart
AMIX Signal Track Record
How signals performed across all stocks →What AMIX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 14 | -8.9% | 29% | September 25, 2026 |
| Bollinger Band Breakdown | 8 | -0.9% | 50% | October 5, 2026 |
| Bollinger Band Breakout | 5 | -31.8% | 0% | August 4, 2026 |
| Any 20-session window (baseline) | -12.1% | 26% |
Computed by MarketWall from daily closing prices since November 11, 2024. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About AMIX
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Website
- autonomix.com/
Fundamentals
- 1-day range
- $3.1$3.16
- Market cap
- $11.82M
- P/E (trailing)
- —
- P/E (forward)
- -0.42
- EPS (trailing)
- $-46.50
- Dividend yield
- —
- Beta
- -0.93
- Avg. volume
- 4.50M
Forecasts
2 analyst ratings
Autonomix Medical Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- AMIXAutonomix Medical Inc. Common Stock$2.85▼ 2.90%Market cap $11.82MP/E —$2.44$32.55
- ICUSeaStar Medical Holding Corporation Common Stock$2.9▼ 5.23%Market cap $12.19MP/E —$2.07$7.35
- MODDModular Medical Inc. Common Stock$2.32▲ 7.18%Market cap $10.99MP/E —$1.72$18.76
- ICCMIceCure Medical Ltd. Ordinary Shares$1.06▲ 1.92%Market cap $10.55MP/E —$1.04$29.46
- SINTSiNtx Technologies Inc. Common Stock$1.74▼ 1.69%Market cap $10.36MP/E —$1.4$4.5
- NMTCNeuroOne Medical Technologies Corporation Common Stock$0.961▼ 7.60%Market cap $13.36MP/E —$0.9615$6.96
- CODXCo-Diagnostics Inc. Common Stock$0.654▼ 8.53%Market cap $9.91MP/E —$0.746$46.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| AMIX Autonomix Medical Inc. Common Stock | $11.82M | — | $2.85 | ▼ 2.90% | $2.44$32.55 |
| ICU SeaStar Medical Holding Corporation Common Stock | $12.19M | — | $2.9 | ▼ 5.23% | $2.07$7.35 |
| MODD Modular Medical Inc. Common Stock | $10.99M | — | $2.32 | ▲ 7.18% | $1.72$18.76 |
| ICCM IceCure Medical Ltd. Ordinary Shares | $10.55M | — | $1.06 | ▲ 1.92% | $1.04$29.46 |
| SINT SiNtx Technologies Inc. Common Stock | $10.36M | — | $1.74 | ▼ 1.69% | $1.4$4.5 |
| NMTC NeuroOne Medical Technologies Corporation Common Stock | $13.36M | — | $0.961 | ▼ 7.60% | $0.9615$6.96 |
| CODX Co-Diagnostics Inc. Common Stock | $9.91M | — | $0.654 | ▼ 8.53% | $0.746$46.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural ValidationYahoo · 10/2/2026
- Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. ClearanceYahoo · 9/30/2026
- Autonomix Medical Completes Pre-Submission Meeting With FDA For Its Transvascular Sensing PlatformBenzinga · 9/30/2026
- Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation PlatformYahoo · 9/24/2026
- Autonomix Medical Receives European Patent Titled Systems For Assessing Neural Activity In An EyeBenzinga · 9/24/2026
- Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of DirectorsYahoo · 9/16/2026
Insider Activity
Insider Actions →- Smith Trent N. · September 3, 2026 · Grant15.0K
- KLEMP WALTER V · September 3, 2026 · Grant13.0K
- Bisson Lori · September 3, 2026 · Grant13.0K
- Hauser Bradley · September 3, 2026 · Grant27.0K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Autonomix Gets Positive FDA Feedback, Completes Pre-Submission Meeting
The company reported that the FDA gave positive feedback that supports a 510(k) clearance pathway for its product. It also completed a pre‑submission meeting with the agency regarding its transvascular sensing platform. These steps move the regulatory process forward and may affect the company's future prospects. The stock is currently near its $7.83 support level.
Autonomix Gets Positive FDA Feedback, Completes Pre-Submission Meeting. The company reported that the FDA gave positive feedback that supports a 510(k) clearance pathway for its product. It also completed a pre‑submission meeting with the agency regarding its transvascular sensing platform. These steps move the regulatory process forward and may affect the company's future prospects. The stock is currently near its $7.83 support level.